Jonathan Goldman Avalo Therapeutics, Inc. (AVTX) insider trading activity

AVTX Quotes by TradingView

Jonathan Goldman is Director of Avalo Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AVTX, which is worth approximately $0. The most recent transaction as insider was on Nov 14, 2025, when has been sold 11,367 shares (Common Stock) at a price of $14.33 per share, resulting in proceeds of $162,889. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Jonathan Goldman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2025
SELL
Open market or private sale
$162,889 $14.33 p/Share
11,367 Reduced 100.0%
0 Common Stock
Nov 14 2025
BUY
Exercise of conversion of derivative security
$81,016 $9.88 p/Share
8,200 Added 50.0%
8,200 Common Stock
Mar 28 2025
BUY
Exercise of conversion of derivative security
-
3,167 Added 50.0%
3,167 Common Stock
JG

Jonathan Goldman

Director
Rockville, MD

Track Institutional and Insider Activities on AVTX

Follow Avalo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTX shares.

Notify only if

Insider Trading

Get notified when an Avalo Therapeutics, Inc. insider buys or sells AVTX shares.

Notify only if

News

Receive news related to Avalo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVTX